Sign Up Today and Learn More About BioAge Labs Stock
Invest in or calculate the value of your shares in BioAge Labs or other pre-IPO companies through EquityZen's platform.
BioAge Labs Stock (BILB)
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
About BioAge Labs Stock
Founded
2015
Headquarters
Richmond, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
BioAge Labs Press Mentions
Stay in the know about the latest news on BioAge Labs
BIOA SHAREHOLDER REPORT: BioAge Labs Investors with Losses are Notified to Contact BFA Law before Expiration of March 10 Class Action Deadline
newsfilecorp • Jan 14, 2025
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
newsfilecorp • Jan 14, 2025
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class Action - BIOA
prnewswire • Jan 14, 2025
ROSEN, A LEADING LAW FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIOA
globenewswire • Jan 14, 2025
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages BioAge Labs, Inc. (BIOA) Investors To Inquire About Securities Fraud Class Action
businesswire • Jan 14, 2025
BioAge Labs Management
Leadership team at BioAge Labs
CEO & Co-Founder
Kristen Fortney
Co-founder and COO
Eric Morgen
Join now and verify your accreditation status to gain access to:
- BioAge Labs current valuation
- BioAge Labs stock price
- Available deals in BioAge Labs and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading BioAge Labs Stock
How to invest in BioAge Labs stock?
Accredited investors can buy pre-IPO stock in companies like BioAge Labs through EquityZen funds. These investments are made available by existing BioAge Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell BioAge Labs stock?
Shareholders can sell their BioAge Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
